Epizyme, Inc.
EPZMDelisted Aug 12, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001571498
Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Epizyme, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 132 | +17 |
| Shares | 93.7M | 3.84M | 84.8M | −5.06M (−5.6%) |
| Value | $479.9M | $19.7M | $212.1M | −$248.1M (−53.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Epizyme, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (20)
Institutions that held Epizyme, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Foresite Capital Management III, LLC | 998,278 | $5.11M |
| Rafferty Asset Management, LLC | 238,344 | $1.22M |
| Duality Advisers, LP | 133,513 | $684.0K |
| Voloridge Investment Management, LLC | 107,566 | $551.0K |
| Candriam Luxembourg S.C.A. | 66,329 | $340.0K |
| Woodstock Corp | 62,183 | $318.0K |
| Dimensional Fund Advisors LP | 61,853 | $317.0K |
| Virtus ETF Advisers LLC | 51,919 | $266.0K |
| Caption Management, LLC | 44,445 | $228.0K |
| DekaBank Deutsche Girozentrale | 32,300 | $165.0K |
| Sage Mountain Advisors LLC | 24,273 | $124.0K |
| Handelsbanken Fonder AB | 23,400 | $120.0K |
| E Fund Management Co., Ltd. | 13,338 | $68.0K |
| Simplex Trading, LLC | 7,717 | $65.0K |
| Cambridge Investment Research Advisors, Inc. | 12,500 | $64.0K |
| Bridgefront Capital, LLC | 10,932 | $56.0K |
| Penserra Capital Management LLC | 2,340 | $11.0K |
| Dark Forest Capital Management LP | 1,512 | $8.00K |
| Parkside Financial Bank & Trust | 530 | $3.00K |
| Harbour Investments, Inc. | 200 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Epizyme, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| KPCB XIII Associates, LLC | 3,838,166 | $19.7M |